Olympus Corporation (7733)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Olympus Corporation (7733) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011739
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Olympus Corporation (Olympus) is a manufacturer of precision machineries and instruments. The company develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers a wide range of products including digital SLR systems, digital cameras, voice recorders, film cameras, binoculars, medical endoscope and surgical products, microscopes, industrial scopes, ultrasonic and eddy current instruments, and micro cantilevers, among others. It offers these products through three business lines namely Scientific Solutions business, Camera and Audio business and Medical business. Olympus conducts its operations through subsidiaries in the Americas, Europe and Asia-Pacific. The company is headquartered in Tokyo, Japan.

Olympus Corporation (7733) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Olympus Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Olympus Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Olympus Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Olympus Corporation, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Olympus Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Olympus Corporation, Medical Equipment, Deal Details 13
Asset Purchase 13
OLYMPUS Completes Acquisition Of OP-1 Product Line From Stryker 13
Partnerships 15
Olympus America Enters Into Licensing Agreement With Carl Zeiss MicroImaging 15
Olympus America Enters Into Licensing Agreement With Leica Microsystems 16
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 17
gMed Canada Enters into Distribution Agreement with Olympus Canada 18
Olympus Enters into Distribution Agreement with Amico 19
Terumo Enters into Distribution Agreement with Olympus Medical Systems 20
VIDA Diagnostics Expands Agreement with Olympus Respiratory America 21
Olympus Medical Enters into Distribution Agreement with Terumo Corporation 22
Terumo Expands Distribution Agreement with Olympus 23
Olympus Enters into Distribution Agreement with BrainLAB 24
Olympus and Hitachi Aloka Medical Expands Agreement 25
Sony And Olympus Form Joint Venture To Develop Surgical Endoscopes And Other Medical Devices 26
Olympus Europa Holding Enters Into Distribution Agreement With Applied Spectral Imaging For GenASIs 28
Equity Offering 29
Olympus Announces Private Placement Of Shares For US$1.17 Billion 29
Debt Offering 30
Olympus to Raise USD91 Million in Public Offering of 0.22% Bonds Due 2022 30
Asset Transactions 31
Brooklyn Hospital Center Acquires Evis Exera III From Olympus Europa 31
Acquisition 32
JPMorgan Chase to Acquire 5% Stake in Olympus from Sony for USD390 million 32
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 33
Sony Completes Acquisition Of 11.46% Stake In Olympus For US$643.7 Million 34
Olympus Corporation – Key Competitors 35
Olympus Corporation – Key Employees 36
Olympus Corporation – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Joint Venture 41
Recent Developments 42
Strategy And Business Planning 42
May 16, 2016: VIDA and Olympus Expand Strategic Partnership 42
Feb 10, 2016: Xacti, nac Image Technology, Meitu, Autel, and 3db Hardware Technology join the Micro Four Thirds System Standard Group 43
Corporate Communications 44
Apr 25, 2016: Olympus Promotes Donna Miller to Head of HQ Legal/Global General Counsel and Caroline West to Global Chief Compliance Officer 44
Legal and Regulatory 45
May 02, 2016: A.G. Schneiderman Announces $306 Million National Settlement With Olympus 45
Product News 46
Nov 09, 2017: Olympus Launches Two Types of Upright FV3000 Confocal Laser Scanning Microscope 46
Nov 07, 2017: Launch of the SpinSR10 Super-Resolution Imaging System 47
Oct 13, 2017: Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations 48
Apr 05, 2016: Olympus Announces Global Launch Of FLUOVIEW FV3000 and FV3000RS 49
Jan 26, 2016: Launch of BX53M/BXFM System Microscope 50
Other Significant Developments 51
Jun 12, 2017: Image Stream Medical and Olympus introduce MedPresence, the first Virtual Medical Presence Solution for the Hospital Enterprise 51
May 06, 2016: Olympus Partners with King’s College Hospital to Deliver Britain’s Largest 3D Surgical Endoscopy Installation and Improve Efficiency in Surgery 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Olympus Corporation, Medical Equipment, Key Facts, 2017 2
Olympus Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Olympus Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Olympus Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Olympus Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Olympus Corporation, Deals By Market, 2011 to YTD 2017 9
Olympus Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
OLYMPUS Completes Acquisition Of OP-1 Product Line From Stryker 13
Olympus America Enters Into Licensing Agreement With Carl Zeiss MicroImaging 15
Olympus America Enters Into Licensing Agreement With Leica Microsystems 16
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 17
gMed Canada Enters into Distribution Agreement with Olympus Canada 18
Olympus Enters into Distribution Agreement with Amico 19
Terumo Enters into Distribution Agreement with Olympus Medical Systems 20
VIDA Diagnostics Expands Agreement with Olympus Respiratory America 21
Olympus Medical Enters into Distribution Agreement with Terumo Corporation 22
Terumo Expands Distribution Agreement with Olympus 23
Olympus Enters into Distribution Agreement with BrainLAB 24
Olympus and Hitachi Aloka Medical Expands Agreement 25
Sony And Olympus Form Joint Venture To Develop Surgical Endoscopes And Other Medical Devices 26
Olympus Europa Holding Enters Into Distribution Agreement With Applied Spectral Imaging For GenASIs 28
Olympus Announces Private Placement Of Shares For US$1.17 Billion 29
Olympus to Raise USD91 Million in Public Offering of 0.22% Bonds Due 2022 30
Brooklyn Hospital Center Acquires Evis Exera III From Olympus Europa 31
JPMorgan Chase to Acquire 5% Stake in Olympus from Sony for USD390 million 32
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 33
Sony Completes Acquisition Of 11.46% Stake In Olympus For US$643.7 Million 34
Olympus Corporation, Key Competitors 35
Olympus Corporation, Key Employees 36
Olympus Corporation, Other Locations 38
Olympus Corporation, Subsidiaries 39
Olympus Corporation, Joint Venture 41

★海外企業調査レポート[Olympus Corporation (7733)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SARcode Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SARcode Corporation Mergers and …
  • Matrix I.T. Ltd. (MTRX):企業財務及び戦略的SWOT分析
    Summary Matrix I.T. Ltd. (Matrix) is an information technology service provider that offers medical technological solutions. The company’s services include representing software products, strategic consulting, call centers, outsourcing and offshore, professional services, development and implementat …
  • Spineway SAS (ALSPW):企業のM&A・提携動向(医療機器分野)
    Summary Spineway SAS (Spineway) is a medical device company that offers design, manufacturing and commercialization of surgical implants and instruments. The company offers a wide range of cervical, thoraco-lumbar, mini invasive products and other bio materials. Its cervical products include Ayers R …
  • Travelzest plcの企業概要及び財務/SWOT分析
    Travelzest plc Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly foreca …
  • Energate Inc.:企業のM&A・提携動向(発電分野)
    Summary Energate Inc. (Energate) is a developer and provider of energy management solutions and products. The product line of the company includes energy management solutions including software, portals, mobile applications, and wireless devices such as gateways, smart thermostats, load control swit …
  • Advent Capital (Holdings) Ltd:企業の戦略・SWOT・財務分析
    SummaryAdvent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Elektroprojekt d.d. (ELKP-R-A):企業財務及び戦略的SWOT分析
    Summary Elektroprojekt d.d. (Elektroprojekt) is a construction company that offers civil and architectural engineering services. The company offers civil and architectural engineering, mechanical and process engineering; electrical engineering and telecommunication, and in-house project management s …
  • Whole Foods Market, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Whole Foods Market, Inc. Merger …
  • j2 Global, Inc.:企業のM&A・提携・投資分析
    j2 Global, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's j2 Global, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Energias de Portugal S.A. (EDP):企業のM&A・提携動向(石油・ガス分野)
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and explores for, produces, transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation ass …
  • FAREVA Holding:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' FAREVA Holding Mergers and Acqu …
  • GlaxoSmithKline Plc:企業のM&A・提携・投資分析
    GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • St. George’s University of London-製薬・医療分野:企業M&A・提携分析
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthc …
  • Bank Handlowy w Warszawie S.A. (BHW):企業の財務及び戦略的SWOT分析
    Summary Bank Handlowy w Warszawie S.A. (BHW), a subsidiary of Citigroup Inc. is a financial service provider that provides corporate and investment banking, and retail banking services. The bank offers services,which include lending and deposit services, trade financing, cash management, factoring, …
  • Olink Proteomics AB-医療機器分野:企業M&A・提携分析
    Summary Olink Proteomics AB (Olink) is a biotechnology company that provides products and services for human protein biomarker research. The company’s portfolio of products includes biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. Olin …
  • Sanofi K.K.(製薬・医療分野):企業M&A動向
    Summary Sanofi K.K. (Sanofi) formerly sanofi-aventis K.K., is a pharmaceutical company. The company researches, develops, manufactures and markets therapeutic solutions. It offers products in the areas of diabetes, oncology, human vaccines, rare diseases, multiple sclerosis, other products, consumer …
  • Italfarmaco S.p.A.(製薬・医療分野):企業M&A動向
    Summary Italfarmaco S.p.A. (Italfarmaco) is a pharmaceutical company. The company manufactures and research pharmaceutical products for the diseases that influence human health primarily in cardiovascular and immuno-oncological areas. Its products include liquid oral drugs, injectables, solid oral d …
  • Haemonetics Corp (HAE)-医療機器分野:企業M&A・提携分析
    Summary Haemonetics Corp (Haemonetics) is a healthcare company, which offers blood management technology and software solutions. The company’s portfolio consists of integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehe …
  • Asahi Organic Chemicals Industry Co., Ltd. (4216):企業財務及び戦略的SWOT分析
    Summary Asahi Organic Chemicals Industry Co., Ltd. (AOC), a subsidiary of Asahi Kasei Corporation is a chemical company that manufactures plastic valves. The company operates business through the divisions piping materials, foundry materials and functional resins, and water treatment and natural res …
  • True Value Company:企業の戦略・SWOT・財務分析
    SummaryTrue Value Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆